150 related articles for article (PubMed ID: 32382359)
1. Multiple Relapses of Visceral Leishmaniasis in HIV Co-Infected Patients: A Case Series from Ethiopia.
Mohammed R; Fikre H; Schuster A; Mekonnen T; van Griensven J; Diro E
Curr Ther Res Clin Exp; 2020; 92():100583. PubMed ID: 32382359
[TBL] [Abstract][Full Text] [Related]
2. Diversity and Within-Host Evolution of Leishmania donovani from Visceral Leishmaniasis Patients with and without HIV Coinfection in Northern Ethiopia.
Franssen SU; Takele Y; Adem E; Sanders MJ; Müller I; Kropf P; Cotton JA
mBio; 2021 Jun; 12(3):e0097121. PubMed ID: 34182785
[TBL] [Abstract][Full Text] [Related]
3. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
[TBL] [Abstract][Full Text] [Related]
4. The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.
Abongomera C; Diro E; de Lima Pereira A; Buyze J; Stille K; Ahmed F; van Griensven J; Ritmeijer K
PLoS Negl Trop Dis; 2018 May; 12(5):e0006527. PubMed ID: 29799869
[TBL] [Abstract][Full Text] [Related]
5.
van Griensven J; Mengesha B; Mekonnen T; Fikre H; Takele Y; Adem E; Mohammed R; Ritmeijer K; Vogt F; Adriaensen W; Diro E
Front Cell Infect Microbiol; 2018; 8():94. PubMed ID: 29651411
[No Abstract] [Full Text] [Related]
6. The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study.
Abongomera C; Diro E; Vogt F; Tsoumanis A; Mekonnen Z; Admassu H; Colebunders R; Mohammed R; Ritmeijer K; van Griensven J
Clin Infect Dis; 2017 Oct; 65(10):1703-1710. PubMed ID: 29020196
[TBL] [Abstract][Full Text] [Related]
7. Chronic high level parasitemia in HIV-infected individuals with or without visceral leishmaniasis in an endemic area in North-West Ethiopia: potential superspreaders?
van Griensven J; van Henten S; Kibret A; Kassa M; Beyene H; Abdellati S; de Hondt A; Adriaensen W; Vogt F; Pareyn M; Ritmeijer K; Diro E
Clin Infect Dis; 2024 Jan; ():. PubMed ID: 38193647
[TBL] [Abstract][Full Text] [Related]
8. Recurrent visceral leishmaniasis relapses in HIV co-infected patients are characterized by less efficient immune responses and higher parasite load.
Takele Y; Mulaw T; Adem E; Womersley R; Kaforou M; Franssen SU; Levin M; Taylor GP; Müller I; Cotton JA; Kropf P
iScience; 2023 Feb; 26(2):105867. PubMed ID: 36685039
[TBL] [Abstract][Full Text] [Related]
9. Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review.
Cota GF; de Sousa MR; Rabello A
PLoS Negl Trop Dis; 2011 Jun; 5(6):e1153. PubMed ID: 21666786
[TBL] [Abstract][Full Text] [Related]
10. Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome).
Burza S; Mahajan R; Sinha PK; van Griensven J; Pandey K; Lima MA; Sanz MG; Sunyoto T; Kumar S; Mitra G; Kumar R; Verma N; Das P
PLoS Negl Trop Dis; 2014 Aug; 8(8):e3053. PubMed ID: 25101665
[TBL] [Abstract][Full Text] [Related]
11. Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?
Salih NA; van Griensven J; Chappuis F; Antierens A; Mumina A; Hammam O; Boulle P; Alirol E; Alnour M; Elhag MS; Manzi M; Kizito W; Zachariah R
Trop Med Int Health; 2014 Feb; 19(2):146-52. PubMed ID: 24433217
[TBL] [Abstract][Full Text] [Related]
12. Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil.
Cota GF; de Sousa MR; de Mendonça AL; Patrocinio A; Assunção LS; de Faria SR; Rabello A
PLoS Negl Trop Dis; 2014 Apr; 8(4):e2816. PubMed ID: 24743472
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life of HIV infected adults with and without Visceral Leishmaniasis in Northwest Ethiopia.
Alemayehu M; Wubshet M; Mesfin N; Tamiru A; Gebayehu A
Health Qual Life Outcomes; 2017 Aug; 15(1):65. PubMed ID: 28851361
[TBL] [Abstract][Full Text] [Related]
14. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
Medrano FJ; Hernández-Quero J; Jiménez E; Pineda JA; Rivero A; Sánchez-Quijano A; Velez ID; Viciana P; Castillo R; Reyes MJ
AIDS; 1992 Dec; 6(12):1499-503. PubMed ID: 1362880
[TBL] [Abstract][Full Text] [Related]
15. Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study.
Diro E; Ritmeijer K; Boelaert M; Alves F; Mohammed R; Abongomera C; Ravinetto R; De Crop M; Fikre H; Adera C; Colebunders R; van Loen H; Menten J; Lynen L; Hailu A; van Griensven J
PLoS Negl Trop Dis; 2015; 9(10):e0004087. PubMed ID: 26431253
[TBL] [Abstract][Full Text] [Related]
16. Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections.
Russo R; Laguna F; López-Vélez R; Medrano FJ; Rosenthal E; Cacopardo B; Nigro L
Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():99-105. PubMed ID: 14678637
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal evaluation of asymptomatic Leishmania infection in HIV-infected individuals in North-West Ethiopia: A pilot study.
van Griensven J; van Henten S; Mengesha B; Kassa M; Adem E; Endris Seid M; Abdellati S; Asefa W; Simegn T; Debasu D; Bogale T; Gedamu Y; Van Den Bossche D; Adriaensen W; Van der Auwera G; Cnops L; Vogt F; Diro E
PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007765. PubMed ID: 31593563
[TBL] [Abstract][Full Text] [Related]
18. Leishmania / HIV co-infections.
Desjeux P
Afr Health; 1995 Nov; 18(1):20-2. PubMed ID: 12290565
[TBL] [Abstract][Full Text] [Related]
19. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
Zijlstra EE
PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
[TBL] [Abstract][Full Text] [Related]
20. Antigen Detection in Urine for Noninvasive Diagnosis and Treatment Monitoring of Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients: An Exploratory Analysis from Ethiopia.
Vogt F; Mengesha B; Asmamaw H; Mekonnen T; Fikre H; Takele Y; Adem E; Mohammed R; Ritmeijer K; Adriaensen W; Melsew Y; van Griensven J; Diro E
Am J Trop Med Hyg; 2018 Oct; 99(4):957-966. PubMed ID: 30084342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
